41.389 articles found

Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease.

Deane KH, Spieker S, Clarke CE.

Cochrane Database Syst Rev · 2004-10-18

DOI: 10.1002/14651858.cd004554.pub2PMID: 15495119

Biomarkers of neurodegenerative disorders: How good are they?

Varun Rachakonda1, Tian Hong Pan1, Wei Dong Le.

Cell research · 2004-10-01

Neurodegenerative diseases caused by protein aggregation: a phenomenon at the borderline between molecular evolution and ageing.

Stoppini M, Andreola A, Foresti G, Bellotti V.

Pharmacol Res · 2004-10-01

DOI: 10.1016/j.phrs.2003.12.025PMID: 15304239

Cholinesterase inhibitors: new roles and therapeutic alternatives.

Giacobini E.

Pharmacol Res · 2004-10-01

DOI: 10.1016/j.phrs.2003.11.017PMID: 15304240

Acute ventricular rate control in atrial fibrillation and atrial flutter.

Khan IA, Nair CK, Singh N, Gowda RM, Nair RC.

Int J Cardiol · 2004-10-01

DOI: 10.1016/j.ijcard.2003.08.006PMID: 15336799

Retinoic acid signaling in the nervous system of adult vertebrates.

Mey J, McCaffery P.

Neuroscientist · 2004-10-01

DOI: 10.1177/1073858404263520PMID: 15359008

The role of tau (MAPT) in frontotemporal dementia and related tauopathies.

Rademakers R, Cruts M, van Broeckhoven C.

Hum Mutat · 2004-10-01

DOI: 10.1002/humu.20086PMID: 15365985

Is major depression a neurologic disorder with psychiatric symptoms?

Kanner AM.

Epilepsy Behav · 2004-10-01

DOI: 10.1016/j.yebeh.2004.07.008PMID: 15380113

SMi 4th Annual Conference on Neurodegenerative Disorders: a focus on Alzheimer's and Parkinson's disease.

O'Neill MJ.

Expert Opin Investig Drugs · 2004-10-01

DOI: 10.1517/13543784.13.10.1369PMID: 15461566

Distribution, type, and origin of Parkin mutations: review and case studies.

Hedrich K, Eskelson C, Wilmot B, Marder K, Harris J, Garrels J, Meija-Santana H, Vieregge P, Jacobs H, Bressman SB, Lang AE, Kann M, Abbruzzese G, Martinelli P, Schwinger E, Ozelius LJ, Pramstaller PP, Klein C, Kramer P.

Mov Disord · 2004-10-01

DOI: 10.1002/mds.20234PMID: 15390068

Brain-derived neurotrophic factor as a drug target for CNS disorders.

Pezet S, Malcangio M.

Expert Opin Ther Targets · 2004-10-01

DOI: 10.1517/14728222.8.5.391PMID: 15469390

[Practical attitude toward arrhythmia in the neonate and infant].

Lupoglazoff JM, Denjoy I.

Arch Pediatr · 2004-10-01

DOI: 10.1016/j.arcped.2004.02.010PMID: 15475291